Ozanimod▼ is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active ...

"The Great Flattening Trend" is an effort to eliminate middle managers, streamline work and cut costs, but critics say the ...

Firefly Neuroscience (AIFF) highlights two impactful studies that demonstrate the utility of advanced Resting Electroencephalograms and ...

Koshinski Asset Management Inc. boosted its holdings in Novartis AG (NYSE:NVS – Free Report) by 6.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission ...

The China-based cancer drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.

A research team from Columbia Engineering and the Irving Institute for Cancer Dynamics made a pivotal discovery in the field ...

On December 27, 2024, the United States Court of Appeals for the Second Circuit decided United States ex rel. Camburn v. Novartis ...

Protein degradation–focused Neomorph nabs its third Big Pharma deal of around $1.5 billion in less than a year.

What Happened: The latest Form 4 filing on Wednesday with the U.S. Securities and Exchange Commission uncovered CAGNONI, ...

Avadel Pharmaceuticals appointed Sev Melkonian as VP of patient services, distribution and reimbursement. Experity appointed ...